Jonathan Goldman is the founder of Abzena plc. Abzena plc has raised $65M in total funding. Latest round: Growth. Based in Cambridge, United Kingdom.
Jonathan Goldman, MD, was appointed Chief Executive Officer (CEO) of Abzena plc following the company's acquisition by Welsh, Carson, Anderson & Stowe (WCAS). He serves as the current CEO of the antibody-drug conjugate specialist and integrated biologics partner.
Full founder directory · Investor directory · Company funding database · Fundraising library